vendredi 11 septembre 2020

Children's Health Defense: COVID-19 Vaccine Participant Develops Neurological Symptoms, AstraZeneca Pauses Trial

Leggi l'articolo:
https://childrenshealthdefense.org/news/covid-19-vaccine-participant-develops-neurological-symptoms-astrazeneca-pauses-trial/?htm_source=salsa&eType=EmailBlastContent&eId=362cc1c6-4ad0-472f-9cd5-3ff16de1f106&cn-reloaded=1

"While AstraZeneca says the woman has not been officially diagnosed, an anonymous source told the New York Times that the woman’s symptoms were consistent with transverse myelitis (TM)."

"Patients can become severely disabled and there is currently no effective cure"

"Concerns over associations between TM and vaccines are well known. A review of published case studies in 2009 documented 37 cases of transverse myelitis associated with vaccines, including Hepatitis B, measles-mumps-rubella, diphtheria, pertussis, tetanus and others in infants, children and adults. The researchers in Israel noted “the associations of different vaccines with a single autoimmune phenomenon allude to the idea that a common denominator of these vaccines, such as an adjuvant, might trigger this syndrome.” Even the New York Times piece on the recent AstraZeneca trial pause notes past “speculation” that vaccines might be able to trigger TM.


Perhaps the most infamous example of this phenomenon is the case of Colton Berrett. Berrett received Merck’s HPV vaccine at age 13 after doctors advised his mother it would help prevent cervical cancer in his hypothetical wife down the line. After the vaccine, doctors diagnosed Berrett with TM, and the boy became increasingly paralyzed as his spine became increasingly inflamed. Doctors said he’d eventually lose the ability to breathe and the family chose to intubate him. After years of living with this disability, and needing someone to carry a breathing apparatus for him at all times, Berrett took his own life.
Even if AstraZeneca’s vaccine is found responsible for the trial participant’s TM symptoms, that may not become the official conclusion. In July, another participant developed symptoms of TM, and the vaccine trial was paused. But an “independent panel” concluded the illness was unrelated to the vaccine, and the trial continued.
As Nikolai Petrovsky from Flinders University told the Australian Broadcasting Corporation, these panels are “typically made up of doctors, a biostatistician and a medical representative of the sponsor company running the trial.”
It’s unclear if the panel that reviewed the first case of TM will be the same group of experts to decide if the second case of TM was caused by the vaccine, but the Oxford team seems to be laying the groundwork for another such conclusion."
"Also of significance is the fact that researchers have yet to produce a safe and effective vaccine against any coronavirus. When researchers were experimenting on vaccines against SARS (similar to COVID-19 in that it infects the lungs), trials were halted completely, after the vaccinated animals developed even more severe (and sometimes fatal) versions of SARS than the unvaccinated animals."

"As Forbes reported in May, all six monkeys injected with AstraZeneca’s COVID-19 vaccine became infected with COVID-19 after being inoculated. Then, all the monkeys were put to death, meaning the public won’t know if other issues were to have developed.
Adding obscurity to the AstraZeneca trial results is the fact that control groups are given Pfizer’s Nimenrix, a meningitis and pneumonia vaccine."

"Robert F. Kennedy Jr., chief legal counsel and chairman of Children’s Health Defense, explains, “Since none of these companies have ever had to test their products for safety against a true inert placebo, they have always been able to dismiss these sort of tragic outcomes as sad ‘coincidence.'”
Furthermore, AstraZeneca is no stranger to hiding negative trial data from the public eye. DrugWatch.com has documented this pattern at length. For example, the company knowingly and systematically hid results showing that its antipsychotic drug Seroquel was either ineffective or harmful, which is revealed in company emails. (AstraZeneca had to pay $520 million to the U.S. Department of Justice and $647 million in settlements after covering up Seroquel’s side effects.)"
(...) continua